SSGJ-705 combined with chemotherapy

DRUG2 trials

Sponsors

Shenyang Sunshine Pharmaceutical Co., LTD.

Conditions

Locally Advanced (Unresectable) or Metastatic Solid TumorsLocally Advanced, Recurrent or Metastatic Malignancies

Phase 2

SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors

RecruitingNCT07022002

Shenyang Sunshine Pharmaceutical Co., LTD.Locally Advanced, Recurrent or Metastatic Malignancies

Start: 2025-07-30End: 2027-12-12Target: 340Updated: 2025-08-03

SSGJ-705 Plus SSGJ-612 ± Chemotherapy in Advanced HER2-Expressing Solid Tumors

RecruitingNCT07646626

Shenyang Sunshine Pharmaceutical Co., LTD.Locally Advanced (Unresectable) or Metastatic Solid Tumors

Start: 2026-07-17End: 2028-10-31Target: 150Updated: 2026-07-28